GABRB1 Gene Early Infantile Epileptic Encephalopathy Type 45 Genetic Test
Test Details
The GABRB1 gene is associated with early infantile epileptic encephalopathy type 45, which is a rare genetic disorder characterized by seizures and developmental delays. NGS (next-generation sequencing) genetic testing can be used to analyze the GABRB1 gene and identify any mutations or variations that may be responsible for the condition. This type of testing can help with diagnosis and provide valuable information for personalized treatment and management plans.
Test Name: GABRB1 Gene Early Infantile Epileptic Encephalopathy Type 45 Genetic Test
Components:
- Price: 4400.0 AED
Sample Condition:
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Neurological Disorders
Doctor:
Neurologist
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for GABRB1 Gene Early Infantile Epileptic Encephalopathy Type 45 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with GABRB1 Gene Early Infantile Epileptic Encephalopathy Type 45
Test Name | GABRB1 Gene Early infantile epileptic encephalopathy type 45 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GABRB1 Gene Early infantile epileptic encephalopathy type 45 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GABRB1 Gene Early infantile epileptic encephalopathy type 45 |
Test Details | The GABRB1 gene is associated with early infantile epileptic encephalopathy type 45, which is a rare genetic disorder characterized by seizures and developmental delays. NGS (next-generation sequencing) genetic testing can be used to analyze the GABRB1 gene and identify any mutations or variations that may be responsible for the condition. This type of testing can help with diagnosis and provide valuable information for personalized treatment and management plans. |